undamentalytics Newsletter

Angiodynamics Inc balance sheet

At the end of fiscal 2026, Angiodynamics Inc had total assets of $267m, total liabilities of $96.3m and shareholders' equity of $171m. It held $53.9m in cash against $0 of debt: net cash of $53.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Angiodynamics Inc: balance sheet, annual
Fiscal year2010May 20102011May 20112012May 20122013May 20132014May 20142015May 20152016May 20162017May 20172018May 20182019May 20192020May 20202021May 20212022May 20222023May 20232024May 20242025May 20252026May 2026LTMAug 2026
Cash and equivalents5946241618183248742285448294576565434
Receivables—2747486258534539443135525344434845
Inventory—2856556267555539406049515561625255
Total current assets—194158141147151146154168315153141143164193168163143
Goodwill—1623093563603613613612863482012012011590———
Total assets—437720791799773726708705836594561553533318280267242
Accounts payable—1129243323161816231920284038333227
Deferred revenue (current)——32010———————————
Total current liabilities—2554636661677257735158748491767560
Short-term debt—08859165580———————
Long-term debt—6143135138——9187124——25500———
Total debt07150143143701698931330025500000
Total liabilities—32197264262228219193163222139122128154112979678
Shareholders' equity391406523526537545507515543615455439424378206183171164
Net debt (negative = net cash)−59−3912612612452−165018−95−54−48−45−76−56−54−34
Shares outstanding—25m—35m35m36m36m37m37m38m38m39m39m40m40m41m42m42m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ANGO vs PRCTANGO vs STAAANGO vs INGN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Angiodynamics Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Angiodynamics Inc.